Kathy de Graaf

585 total citations
8 papers, 418 citations indexed

About

Kathy de Graaf is a scholar working on Hematology, Immunology and Rheumatology. According to data from OpenAlex, Kathy de Graaf has authored 8 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 5 papers in Immunology and 2 papers in Rheumatology. Recurrent topics in Kathy de Graaf's work include Autoimmune and Inflammatory Disorders Research (5 papers), Immune Cell Function and Interaction (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Kathy de Graaf is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), Immune Cell Function and Interaction (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Kathy de Graaf collaborates with scholars based in Switzerland, United States and Italy. Kathy de Graaf's co-authors include Cristina de Min, Alexei A. Grom, Fabrizio De Benedetti, Philippe Jacqmin, Grant S. Schulert, Denise Pires Marafon, Angelo Ravelli, Claudia Bracaglia, Walter Ferlin and Sergio Davì and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and International Journal of Obesity.

In The Last Decade

Kathy de Graaf

8 papers receiving 409 citations

Peers

Countries citing papers authored by Kathy de Graaf

Since Specialization

Citations

This map shows the geographic impact of Kathy de Graaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy de Graaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy de Graaf more than expected).

Fields of papers citing papers by Kathy de Graaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy de Graaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy de Graaf. The network helps show where Kathy de Graaf may publish in the future.

Co-authorship network of co-authors of Kathy de Graaf

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy de Graaf. A scholar is included among the top collaborators of Kathy de Graaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy de Graaf. Kathy de Graaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study 2019 ·Annals of the Rheumatic Diseases ·(unknown), Ernest Choy, Iain B. McInnes, (unknown), Kathy de Graaf, Philippe Jacqmin, G Lapeyre, Cristina de Min	58
2	OP0204 EMAPALUMAB, AN INTERFERON GAMMA (IFN-Y)-BLOCKING MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) 2019 ·Annals of the Rheumatic Diseases ·Fabrizio De Benedetti, Paul Brogan, Alexei A. Grom, Pierre Quartier, Rayfel Schneider, Kathy de Graaf, Philippe Jacqmin, Maria Ballabio, Cristina de Min	23
3	An Adaptive Design Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients with Non-Primary Hemophagocytic Lymphohistiocytosis 2019 ·Blood ·Veronica Asnaghi, Maria Ballabio, Philippe Jacqmin, Kathy de Graaf, Cristina de Min	1
4	Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 2016 ·Annals of the Rheumatic Diseases ·Claudia Bracaglia, Kathy de Graaf, Denise Pires Marafon, François Guilhot, Walter Ferlin, Giusi Prencipe, Ivan Caiello, Sergio Davì, Grant S. Schulert, Angelo Ravelli, Alexei A. Grom, Cristina de Min, Fabrizio De Benedetti	193
5	Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS 2016 ·Clinical Pharmacology & Therapeutics ·(unknown), G Lapeyre, Eveline P. van Poelgeest, Philippe Jacqmin, Kathy de Graaf, Joannes A. A. Reijers, Matthijs Moerland, Jacobus Burggraaf, Cristina de Min	68
6	High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS 2015 ·Pediatric Rheumatology ·Claudia Bracaglia, Denise Pires Marafon, Ivan Caiello, Kathy de Graaf, François Guilhot, Walter Ferlin, Sergio Davì, Grant S. Schulert, Angelo Ravelli, Alexei A. Grom, Robert D. Nelson, Cristina de Min, Fabrizio De Benedetti	12
7	Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model 2014 ·Pediatric Rheumatology ·Claudia Bracaglia, Ivan Caiello, Kathy de Graaf, Giovanni D’Ario, François Guilhot, (unknown), (unknown), Giusi Prencipe, Sergio Davì, Grant S. Schulert, Angelo Ravelli, Alexei A. Grom, Cristina de Min, Fabrizio De Benedetti	9
8	Energy intake and body weight effects of six months reduced or full fat diets, as a function of dietary restraint 1997 ·International Journal of Obesity ·MS Westerterp-Plantenga, (unknown), (unknown), Kathy de Graaf, (unknown), JA Weststrate	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact